Historical Stock Price
AADI historical stock prices picture
AADI (AADI) has the following price history information. Looking back at AADI historical stock prices for the last five trading days, on March 12, 2025, AADI opened at $1.95, traded as high as $2.01 and as low as $1.94, and closed at $1.98. Trading volume was a total of 63.10K shares. On March 13, 2025, AADI opened at $2.00, traded as high as $2.09 and as low as $1.86, and closed at $1.93. Trading volume was a total of 705.30K shares. On March 14, 2025, AADI opened at $1.97, traded as high as $2.05 and as low as $1.96, and closed at $1.98. Trading volume was a total of 40.90K shares. On March 17, 2025, AADI opened at $1.98, traded as high as $2.12 and as low as $1.96, and closed at $2.10. Trading volume was a total of 52.00K shares. On March 18, 2025, AADI opened at $2.15, traded as high as $2.19 and as low as $2.02, and closed at $2.05. Trading volume was a total of 71.40K shares.

AADI Historical Stock Prices By Date:

AADI historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AADI shares, starting with a $10,000 purchase of AADI, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/20/2018
End date: 03/18/2025
Start price/share: $66.00
End price/share: $2.05
Dividends collected/share: $0.00
Total return: -96.89%
Average Annual Total Return: -38.79%
Starting investment: $10,000.00
Ending investment: $310.45
Years: 7.07
Date Open High Low Close Volume
03/12/2025 $1.95 $2.01 $1.94 $1.98 63.10K
03/13/2025 $2.00 $2.09 $1.86 $1.93 705.30K
03/14/2025 $1.97 $2.05 $1.96 $1.98 40.90K
03/17/2025 $1.98 $2.12 $1.96 $2.10 52.00K
03/18/2025 $2.15 $2.19 $2.02 $2.05 71.40K
Aadi Bioscience, Inc. is a commercial-stage biopharmaceutical company. Co. is focused on developing and commercializing precision therapies for cancers with alterations in the mammalian target of rapamycin (mTOR) pathway, a regulator of cell growth and cancer progression. Its lead drug product, FYARRO, is an mTOR inhibitor indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa). FYARRO is a form of sirolimus bound to albumin. Sirolimus is a potent inhibitor of the mTOR biological pathway and inhibits downstream signaling from mTOR, which can promote tumor growth.
Date Close
03/12/2025$1.98
03/13/2025$1.93
03/14/2025$1.98
03/17/2025$2.10
03/18/2025$2.05
AADI is categorized under the Healthcare sector; below are some other companies in the same sector:

AARD Historical Stock Prices
AAVL Historical Stock Prices
ABAX Historical Stock Prices
ABBV Historical Stock Prices
ABC Historical Stock Prices
ABEO Historical Stock Prices
ABIO Historical Stock Prices
ABMD Historical Stock Prices
ABOS Historical Stock Prices
ABSI Historical Stock Prices

Also explore: AADI shares outstanding history

Email EnvelopeFree AADI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


AADI Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2025, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.